Enterprise Value
1.854M
Cash
102.1M
Avg Qtr Burn
-14.86M
Short % of Float
1.58%
Insider Ownership
0.59%
Institutional Own.
50.11%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
SRF388 (IL-27) Details Solid tumors | Phase 2 Update | |
SRF114 Details Solid tumor/s, Cancer | Phase 1/2 Data readout | |
NZV930 (CD73) Details Solid tumor/s, Cancer | Phase 1 Data readout | |
GSK4381562 Details Solid tumor/s, Cancer | Phase 1 Data readout | |
SRF617 (CD39) Details Solid tumor/s, Cancer | Failed Discontinued |